Following up on our previous post about Gene Therapies, we are sharing data on Genetic Medicines in development - pipelines, targets, dates

The news this week was full of "Ups-n-Downs." We've noted a few here and know there were more surprises with clinical data results, M&A, and

Check out the latest on some of the Opioid Litigation, SPACS, and yes two Top 10 Lists!

The Eyes on Pharma team was caught up in reviewing global R&D trends and following the updates from ASCO-GU ...